Firm infects subjects to seek virus remedy
Cambridge lab starts human trial
It sounds like a reversal of the doctor's pledge to do no harm: The Cambridge biotechnology company Alnylam Pharmaceuticals Inc. is paying 40 healthy people to get sick. (Full article: 1136 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
